Literature DB >> 962995

Distribution of survival times of 12,000 head and neck cancer patients who died with their disease.

R F Mould, T Hearnden, M Palmer, G C White.   

Abstract

The lognormal parametric statistical model can provide, for groups of carcinoma cervix patients, good estimates of long-term survival fractions several years earlier than would otherwise be possible. The present paper extends this model work to head and neck cancer by using a minimum chi-squared test for goodness of fit (P greater than 0-05), to study the distribution of survival times of patients who died with their cancer present. Some 12,000 case histories were available from 7 hospital registries, 4 regional cancer registries and one national registry (the OPCS). All histories were followed up for at least 10 years subsequent to treatment and could be grouped into one of 8 cancer sites: antrum, floor of mouth, larynx, nasopharynx, pyriform fossa, post cricoid, tonsil and tongue. The theoretical distributions investigated were the lognormal, negative exponential and skew exponential. The results showed that the lognormal provided the best overall fit to the data, although the range of optimum values for the lognormal parameter, S, differed with cancer site. The optimum range did, however, usually include the value S=0-45. These results will now permit the second stage of validation of the lognormal model to proceed for head and neck cancers.

Entities:  

Mesh:

Year:  1976        PMID: 962995      PMCID: PMC2025142          DOI: 10.1038/bjc.1976.141

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  7 in total

1.  The estimation of the proportion of patients cured after treatment for cancer of the breast.

Authors:  J L HAYBITTLE
Journal:  Br J Radiol       Date:  1959-11       Impact factor: 3.039

2.  The prognosis for survival in chronic granulocytic and lymphocytic leukemia.

Authors:  H TIVEY
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1954-07

3.  Calculation of survival rates by the life table and other methods.

Authors:  R F Mould
Journal:  Clin Radiol       Date:  1976-01       Impact factor: 2.350

4.  Radiation treatment of cancer of the cervix of the uterus at the Radium Institute in Copenhagen from 1951-54.

Authors:  R F Mould
Journal:  Acta Obstet Gynecol Scand       Date:  1975       Impact factor: 3.636

5.  Carcinoma of the vulva. Cure after operative therapy evaluated in accordance with Boag's statistical method.

Authors:  F Ronnike
Journal:  Dan Med Bull       Date:  1968-12

6.  The distribution of cancer deaths in time. A survey test of the lognormal model.

Authors:  J W Berg
Journal:  Br J Cancer       Date:  1965-12       Impact factor: 7.640

7.  A test of several parametic statistical models for estimating success rate in the treatment of carcinoma cervix uteri.

Authors:  R F Mould; J W Boag
Journal:  Br J Cancer       Date:  1975-11       Impact factor: 7.640

  7 in total
  9 in total

1.  The biology of haematogenous metastasis in human uveal malignant melanoma.

Authors:  I W McLean
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

2.  Short- and long-term cause-specific survival of patients with inflammatory breast cancer.

Authors:  Patricia Tai; Edward Yu; Ross Shiels; Juan Pacella; Kurian Jones; Evgeny Sadikov; Shazia Mahmood
Journal:  BMC Cancer       Date:  2005-10-22       Impact factor: 4.430

3.  On the utility of the lognormal model for analysis of breast cancer survival in Sweden 1961-1973.

Authors:  L E Rutqvist
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

4.  A model of long-term survival following adjuvant therapy for stage 2 breast cancer.

Authors:  J W Gamel; R L Vogel
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

5.  The lognormal distribution as a fit to symptom durations in the range 0-2 years for 26,000 cancer patients.

Authors:  R F Mould; I W Hanham; B F McSweeney; D R Myles
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

6.  Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database.

Authors:  Patricia Tai; Edward Yu; Gábor Cserni; Georges Vlastos; Melanie Royce; Ian Kunkler; Vincent Vinh-Hung
Journal:  BMC Cancer       Date:  2005-05-17       Impact factor: 4.430

7.  Survival outcome and prognostic factors of patients with nasopharyngeal cancer in Yogyakarta, Indonesia: A hospital-based retrospective study.

Authors:  Susanna Hilda Hutajulu; Daniel Howdon; Kartika Widayati Taroeno-Hariadi; Mardiah Suci Hardianti; Ibnu Purwanto; Sagung Rai Indrasari; Camelia Herdini; Bambang Hariwiyanto; Ahmad Ghozali; Henry Kusumo; Wigati Dhamiyati; Sri Retna Dwidanarti; I Bing Tan; Johan Kurnianda; Matthew John Allsop
Journal:  PLoS One       Date:  2021-02-12       Impact factor: 3.240

8.  Squamous carcinoma of the head and neck: cured fraction and median survival time as functions of age, sex, histologic type, and node status.

Authors:  J W Gamel; A S Jones
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

9.  Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries.

Authors:  Patricia Tai; Edward Yu; Vincent Vinh-Hung; Gábor Cserni; Georges Vlastos
Journal:  BMC Cancer       Date:  2004-09-02       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.